120 related articles for article (PubMed ID: 3243977)
1. Phosphohexose isomerase and carcinoembryonic antigen in the sera of patients with primary lung cancer.
Santabárbara P; Molina R; Estapé J; Ballesta AM
Int J Biol Markers; 1988; 3(2):113-22. PubMed ID: 3243977
[TBL] [Abstract][Full Text] [Related]
2. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
[TBL] [Abstract][Full Text] [Related]
3. Significance of serum phosphohexose isomerase in gastrointestinal cancer at different stages.
Baumann M; Brand K; Giedl J; Hermanek P; Ruf S; Scheele J; Hoferichter S; Gall FP
Oncology; 1988; 45(3):153-8. PubMed ID: 3368192
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum CEA, PHI, and TPA as tumor markers in breast cancer patients.
Paulick R; Caffier H; Paulick M
Cancer Detect Prev; 1987; 10(3-4):197-203. PubMed ID: 3568016
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases.
Munjal D; Chawla PL; Lokich JJ; Zamcheck N
Cancer; 1976 Apr; 37(4):1800-7. PubMed ID: 4219
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of different serum tumor markers in gynecological malignancies.
Paulick R; Caffier H; Horner G; Lang K; Filbry E
Cancer Detect Prev; 1985; 8(1-2):115-20. PubMed ID: 4064031
[TBL] [Abstract][Full Text] [Related]
7. [Serum levels of GPI, AAT and CEA in primary lung neoplasms and chronic bronchopneumopathies].
Di Martino G; di Matteo L; De Bellis G; Iannucci F; Molero U; Catena E
Boll Ist Sieroter Milan; 1979 Sep; 58(4):344-55. PubMed ID: 317940
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Jul; 78(1):216-21. PubMed ID: 15223432
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients.
Yasasever V; Dinçer M; Camlica H; Duranyildiz D; Dalay N
Eur J Gynaecol Oncol; 1997; 18(5):397-9. PubMed ID: 9378161
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
Martinez-Vea A; Gatell JM; Segura F; Heiman C; Elena M; Ballesta AM; Mundo MR
Cancer; 1982 Nov; 50(9):1783-8. PubMed ID: 6180821
[TBL] [Abstract][Full Text] [Related]
11. Serum phosphohexose isomerase activities in patients with colorectal cancer.
Filella X; Molina R; Jo J; Mas E; Ballesta AM
Tumour Biol; 1991; 12(6):360-7. PubMed ID: 1798910
[TBL] [Abstract][Full Text] [Related]
12. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
[TBL] [Abstract][Full Text] [Related]
13. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer.
Grunnet M; Sorensen JB
Lung Cancer; 2012 May; 76(2):138-43. PubMed ID: 22153832
[TBL] [Abstract][Full Text] [Related]
14. Serum tumor markers in metastatic breast cancer and course of disease.
Caffier H; Brandau H
Cancer Detect Prev; 1983; 6(4-5):451-7. PubMed ID: 6197167
[TBL] [Abstract][Full Text] [Related]
15. [Combination of cancer markers in the detection and prognosis of digestive system tumors].
de Mello Júnior JP; Giles GR
Arq Gastroenterol; 1986; 23(3):133-44. PubMed ID: 2449153
[TBL] [Abstract][Full Text] [Related]
16. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
18. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
[TBL] [Abstract][Full Text] [Related]
19. Phosphohexose isomerase in hypernephroma. Significance as serum tumor marker, comparison to other glycolytic enzymes and isozyme patterns in normal and tumor tissue.
Baumann M; Lang T; Brand K
Urol Res; 1988; 16(5):345-9. PubMed ID: 3201649
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of resected clinical stage I pulmonary adenocarcinomas with high preoperative levels of serum carcinoembryonic antigen.
Sawabata N; Hirano H; Inoue M; Okumura Y; Asada H; Takeda S; Maeda H
Ann Thorac Surg; 2003 Jul; 76(1):203-7. PubMed ID: 12842541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
